賓仕國際(01705.HK)預計中期純利同比大幅增長170%至180%
格隆匯 11 月 17日丨賓仕國際(01705.HK)公佈,估計與2019年同期純利約390萬港元相比,集團於截至2020年9月30日止6個月期間的純利將錄得約170.0%至180.0%的大幅增長。該純利的大幅增長乃主要由於收取香港政府推出"保就業"計劃下的第一期工資補貼約1190萬港元,惟因2020年2月起爆發新型冠狀病毒病(COVID-19)導致消費意欲疲弱,使集團的零售業務錄得經營虧損而被部分抵銷。
由於市場氣氛可能需要一段時間才能改善,我們將繼續在產品組合和市場推廣方面下工夫,以維持我們的銷售及市場份額。另一方面,集團將實施嚴格的成本控制措施,進一步提升效率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.